Hot Features
プレミアム
Rapport Therapeutics Inc (RAPP)
NASDAQ
登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational sma... Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts. 詳細を表示
A 30% reduction in long episodes was shown to be associated with a 50% or greater reduction in clinical seizures in a post-hoc analysis, validating the biomarker for proof-of-concept studies...
BOSTON and SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated to the discovery and development of small...
Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and operational leadershipRAP-219 MAD-2 and PET trials...
BOSTON and SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of small molecule...
BOSTON and SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of...
BOSTON and SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.42 | 2.20356768101 | 19.06 | 20.22 | 17.01 | 79077 | 18.30136683 | CS |
| 4 | -0.43 | -2.1597187343 | 19.91 | 21.86 | 17.01 | 134612 | 18.98102024 | CS |
| 12 | -0.83 | -4.0866568193 | 20.31 | 29.74 | 17.01 | 108720 | 22.11329979 | CS |
| 26 | -6.01 | -23.577873676 | 25.49 | 29.74 | 16.55 | 133965 | 21.49715388 | CS |
| 52 | 1.48 | 8.22222222222 | 18 | 29.74 | 16.55 | 154109 | 21.88125778 | CS |
| 156 | 1.48 | 8.22222222222 | 18 | 29.74 | 16.55 | 154109 | 21.88125778 | CS |
| 260 | 1.48 | 8.22222222222 | 18 | 29.74 | 16.55 | 154109 | 21.88125778 | CS |
Buysell71
2分前
flipper44
3分前
Monksdream
4分前
Buysell71
4分前
KILLAZILLA
4分前
manibiotech
5分前
Nextbigone
5分前
sortagreen
6分前
JSmith5
6分前
GBR
7分前
Monksdream
7分前
jangofett
8分前
nathanial
9分前
pos_stock_hoarder
9分前
kund
9分前
dbergh
9分前
exwannabe
9分前
Tahoe2468
9分前
splintered sunlight
10分前
eb0783
10分前
JSmith5
10分前
firebag1
11分前
firebag1
12分前
HGilS
15分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
